474 related articles for article (PubMed ID: 7825634)
1. Effects of sex steroids on women's health: implications for practitioners.
Derman RJ
Am J Med; 1995 Jan; 98(1A):137S-143S. PubMed ID: 7825634
[TBL] [Abstract][Full Text] [Related]
2. [Epidemiology, classification and clinical aspects of hyperandrogenemia].
Aganović I; Korsić M
Lijec Vjesn; 1996 Mar; 118 Suppl 1():2-8. PubMed ID: 8759398
[TBL] [Abstract][Full Text] [Related]
3. Androgenic effects of oral contraceptives: implications for patient compliance.
Jones EE
Am J Med; 1995 Jan; 98(1A):116S-119S. PubMed ID: 7825631
[TBL] [Abstract][Full Text] [Related]
4. Contraceptive choices for women with endocrine complications.
Loriaux DL; Wild RA
Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 2):2021-6. PubMed ID: 8512047
[TBL] [Abstract][Full Text] [Related]
5. [Cutaneous effects in hormonal contraception].
Thomas P; Dalle E; Revillon B; Delecour M; Devarenne-nicolle MF; Pagniez I
NPN Med; 1985 Jan; 5(81):19-24. PubMed ID: 12281276
[TBL] [Abstract][Full Text] [Related]
6. [Oral contraception: failures and risks].
Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
[TBL] [Abstract][Full Text] [Related]
7. The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women.
Nader S; Riad-Gabriel MG; Saad MF
J Clin Endocrinol Metab; 1997 Sep; 82(9):3074-7. PubMed ID: 9284746
[TBL] [Abstract][Full Text] [Related]
8. Organic mood disorder associated with the HAIR-AN syndrome.
Levin TR; Terrell TR; Stoudemire A
J Neuropsychiatry Clin Neurosci; 1992; 4(1):51-4. PubMed ID: 1627962
[TBL] [Abstract][Full Text] [Related]
9. [Hormones and lupus].
Gompel A; Pelissier C; Kuttenn F; Mauvais-Jarvis P
Rev Med Interne; 1985 Dec; 6(5):543-52. PubMed ID: 3914021
[TBL] [Abstract][Full Text] [Related]
10. Androgens and women's health.
Redmond GP
Int J Fertil Womens Med; 1998; 43(2):91-7. PubMed ID: 9609208
[TBL] [Abstract][Full Text] [Related]
11. Hirsutism and virilism in women.
Kirschner MA
Spec Top Endocrinol Metab; 1984; 6():55-93. PubMed ID: 6084314
[TBL] [Abstract][Full Text] [Related]
12. Exogenous progestins and breast cancer.
Stanford JL; Thomas DB
Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
[TBL] [Abstract][Full Text] [Related]
13. The role of oral contraceptives in the treatment of hyperandrogenic disorders.
Burkman RT
Am J Med; 1995 Jan; 98(1A):130S-136S. PubMed ID: 7825633
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
Crook D; Godsland IF; Wynn V
Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933
[TBL] [Abstract][Full Text] [Related]
15. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
Hirschberg AL
J Clin Endocrinol Metab; 2023 Apr; 108(5):1243-1253. PubMed ID: 36409990
[TBL] [Abstract][Full Text] [Related]
16. Contraceptive choices in women with coagulation disorders.
Comp PC; Zacur HA
Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 2):1990-3. PubMed ID: 8512043
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk factors and events in women with androgen excess.
Macut D; Antić IB; Bjekić-Macut J
J Endocrinol Invest; 2015 Mar; 38(3):295-301. PubMed ID: 25432327
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid arthritis, the contraceptive pill, and androgens.
James WH
Ann Rheum Dis; 1993 Jun; 52(6):470-4. PubMed ID: 8323402
[TBL] [Abstract][Full Text] [Related]
19. Dermatology of androgen-related disorders.
Essah PA; Wickham EP; Nunley JR; Nestler JE
Clin Dermatol; 2006; 24(4):289-98. PubMed ID: 16828411
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptives as anti-androgenic treatment of acne.
Lemay A; Poulin Y
J Obstet Gynaecol Can; 2002 Jul; 24(7):559-67. PubMed ID: 12196847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
